CAS Number14721-66-5
Synonyms3,7,11,15-Tetramethylhexadecanoic acid; (7R,11R)-3,7,11,15-Tetramethylhexadecanoic acid; Phytanic acid
Molecular FormulaC20H40O2
Molecular Weight312.53
Density0.9±0.1 g/cm3
Boiling Point422.3±13.0 °C at 760 mmHg
Melting Point-65°C
AppearanceTransparent colorless liquid
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 14721-66-5 |
| Catalog No. | 2A-1190857 |
| Chinese Name | 植烷酸 |
| Synonyms | 3,7,11,15-Tetramethylhexadecanoic acid; (7R,11R)-3,7,11,15-Tetramethylhexadecanoic acid; Phytanic acid |
| Molecular Formula | C20H40O2 |
| Molecular Weight | 312.53 |
| Density | 0.9±0.1 g/cm3 |
| Boiling Point | 422.3±13.0 °C at 760 mmHg |
| Melting Point | -65°C |
| Appearance | Transparent colorless liquid |
| Storage Condition | 2-8°C |
| Application | Phytanic acid is an endogenous metabolite present in the blood and can be used to study Zellweger syndrome, α-methylacyl-CoA racemase deficiency, rhizoid chondrodysplasia Punctta, and infantile Refsum |
| HTC | 2915900090 |
| PubChem ID | 4760 |
| SMILES | CC(C)CCCC(C)CCCC(C)CCCC(C)CC(=O)O |
| InChI | InChI=1S/C20H40O2/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-19(5)15-20(21)22/h16-19H,6-15H2,1-5H3,(H,21,22) |
| InChI Key | RLCKHJSFHOZMDR-UHFFFAOYSA-N |
| Hazard Symbols | transportation |
| Bioactivity | Phytanic acid is an endogenous metabolite present in Blood that can be used for the research of Zellweger Syndrome, Alpha Methylacyl CoA Racemase Deficiency, Rhizomelic Chondrodysplasia Punctata and Infantile Refsum Disease[1][2][3][4][5]. Related Catalog Research Areas >> Metabolic Disease Target Human Endogenous Metabolite In Vitro Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1]. References [1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [2]. Budden SS, et al. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children. J Pediatr. 1986 Jan;108(1):33-9. [3]. McLean BN, et al. A new defect of peroxisomal function involving pristanic acid: a case report. J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):396-9. [4]. Baumgartner MR, et al. Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44(5):720-30. [5]. Poll-The BT, et al. Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis. 1986;9(2):169-74. Chemical & Physical Properties Density 0.9±0.1 g/cm3 Boiling Point 422.3±13.0 °C at 760 mmHg Melting Point -65°C Molecular Formula C20H40O2 Molecular Weight 312.530 Flash Point 179.7±11.2 °C Exact Mass 312.302826 PSA 37.30000 LogP 8.54 Vapour Pressure 0.0±2.1 mmHg at 25°C Index of Refraction 1.454 InChIKey RLCKHJSFHOZMDR-UHFFFAOYSA-N SMILES CC(C)CCCC(C)CCCC(C)CCCC(C)CC(=O)O Storage condition 2-8°C |
| Use of | Phytanic acid is an endogenous metabolite present in Blood that can be used for the research of Zellweger Syndrome, Alpha Methylacyl CoA Racemase Deficiency, Rhizomelic Chondrodysplasia Punctata and Infantile Refsum Disease[1][2][3][4][5]. Properties Articles61 Name phytanic acid Synonym More Synonyms Phytanic acid Biological Activity Description Phytanic acid is an endogenous metabolite present in Blood that can be used for the research of Zellweger Syndrome, Alpha Methylacyl CoA Racemase Deficiency, Rhizomelic Chondrodysplasia Punctata and Infantile Refsum Disease[1][2][3][4][5]. Related Catalog Research Areas >> Metabolic Disease Human Endogenous Metabolite References [1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [2]. Budden SS, et al. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children. J Pediatr. 1986 Jan;108(1):33-9. [3]. McLean BN, et al. A new defect of peroxisomal function involving pristanic acid: a case report. J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):396-9. [4]. Baumgartner MR, et al. Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44(5):720-30. [5]. Poll-The BT, et al. Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis. 1986;9(2):169-74. Chemical & Physical Properties Molecular Formula C20H40O2 Exact Mass 312.302826 PSA 37.30000 Index of Refraction 1.454 InChIKey RLCKHJSFHOZMDR-UHFFFAOYSA-N SMILES CC(C)CCCC(C)CCCC(C)CCCC(C)CC(=O)O |
| Tax Rebate | 9.0% |
| Supervision | A. Customs clearance form for inbound goods B. Customs clearance form for outbound goods |
| Inspection | R. Imported food hygiene supervision and inspection S. Export food hygiene supervision and inspection M. Imported commodity inspection N. Exported commodity inspection |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE | 18656-38-7 | 2A-1190850 |
| 1,3-dibenzylurea | 1466-67-7 | 2A-1190852 |
| 1,3-diisopropylurea | 4128-37-4 | 2A-1190853 |
| 1,2-DIBUTYRYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 3355-26-8 | 2A-1190854 |
| 1,2-DIOLEOYL-RAC-GLYCEROL | 3738-74-7 | 2A-1190855 |
| 1,2-DIDECANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 3436-44-0 | 2A-1190858 |
| 1,2-DIHEPTANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 39036-04-9 | 2A-1190859 |
| 1,2-DI 3,7,11,15-TETRAMETHYLHEXADECANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 207131-40-6 | 2A-1190861 |
| 1,2-DIPENTADECANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 3355-27-9 | 2A-1190862 |
| 1,2-DIEICOSANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 61596-53-0 | 2A-1190863 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS